GPER1 and neoplasm: Based on the extensive studies of GPER-binding endocrine actions, the evidence to date evoked substantially different standpoints which were dissociated from the fixed role as a carcinogenesis promotor and unfolded the antitumor activity of GPER in a diverse collection of tumor responses.